| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 130 |
| 1 | METHOTREXATE SODIUM | 100 |
| 2 | METHOTREXATE | 92 |
| 3 | PREDNISONE | 65 |
| 4 | FOLIC ACID | 60 |
| 5 | ETANERCEPT | 58 |
| 6 | ACETAMINOPHEN | 55 |
| 7 | INFLIXIMAB | 55 |
| 8 | ERGOCALCIFEROL | 39 |
| 9 | ACETAMINOPHEN 500MG | 38 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIPROLIDINE HCL, DEXTROMETHORPHAN HBR | 1 | 0.0556 |
| 1 | PHENOXYBENZAMINE HYDROCHLORIDE | 1 | 0.0370 |
| 2 | ANORECTAL OINTMENT | 1 | 0.0046 |
| 3 | FUTIBATINIB | 1 | 0.0045 |
| 4 | CLINDAMYCIN PHOSPHATE | 21 | 0.0038 |
| 5 | NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE | 1 | 0.0038 |
| 6 | TRASTUZUMAB-DKST | 1 | 0.0036 |
| 7 | LINCOMYCIN HYDROCHLORIDE | 1 | 0.0034 |
| 8 | DICLOXACILLIN SODIUM | 3 | 0.0033 |
| 9 | ADALIMUMAB-AACF | 1 | 0.0030 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 165 |
| 1 | Corticosteroid [EPC] | 150 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 110 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 91 |
| 4 | Vitamin C [EPC] | 71 |
| 5 | Vitamin B12 [EPC] | 69 |
| 6 | Atypical Antipsychotic [EPC] | 66 |
| 7 | Vitamin D [EPC] | 65 |
| 8 | Benzodiazepine [EPC] | 57 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 44 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Cortisol Synthesis Inhibitor [EPC] | 1 | 0.0013 |
| 2 | Provitamin D2 Compound [EPC] | 39 | 0.0013 |
| 3 | Dopamine-2 Receptor Antagonist [EPC] | 7 | 0.0009 |
| 4 | Aldehyde Dehydrogenase Inhibitor [EPC] | 1 | 0.0009 |
| 5 | Interleukin-17A Antagonist [EPC] | 31 | 0.0008 |
| 6 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 2 | 0.0008 |
| 7 | Interferon gamma [EPC] | 1 | 0.0007 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 9 | Pyrethroid [EPC] | 1 | 0.0006 |